We are pleased that the latest edition of Skin ‘n’ Bones Connection has now been published. You will notice in this issue that there are reports about how real peoples’ lived experiences are starting to influence research agendas.

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease.

A person's psoriasis or psoriatic arthritis can affect the lives of partners and family members, but this important impact is often ignored.

PAPAA working through our Connect Immune Research partnership, is excited to be part of an innovative new grant call...

The British Psoriatic Arthritis Consortium (BritPACT) worked with the James Lind Alliance (JLA) to run a priority setting partnership (PSP). They have created a national top 10 list of research priorities for psoriatic arthritis, agreed upon by people with psoriatic arthritis, carers and clinicians. This marks the culmination of the psoriasis arthritis PSP.

Bowel Research UK has joined the Connect Immune Research initiative, which includes the type 1 diabetes charity JDRF, the MS Society, Versus Arthritis, the British Society for Immunology, Alopecia UK, the Psoriasis and Psoriatic Arthritis Alliance (PAPAA) and Coeliac UK.

Skin 'n' Bones Connection issue 53 is now available. The journal is aimed at people affected by psoriasis and psoriatic arthritis.

Guselkumab (Tremfya), taken with or without methotrexate, has been recommended by the National Institute for Health and Care Excellence (NICE) and is available on the NHS.

See our new video that is part of our strategy to raise awareness of psoriasis and psoriatic arthritis and includes our mission to look and delve deeper into the causes of psoriatic disease by funding research projects. 

People who use Co-codamol 30/500 Effervescent Tablets, widely used for pain relief, are today being asked to check the batch number on the labels of packs to ensure they are not one of 4,464 packs which are being recalled due to safety concerns.